Jo Varshney, VeriSIM Life CEO
Biosimulation outfit nets $15M Series A in push to make preclinical R&D more predictable
VeriSIM Life has been working on creating a biosimulation platform since its founding in 2017 — and after more than four years and a pre-seed and …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
